Index RUT
P/E 25.13
EPS (ttm) 5.12
Insider Own 2.15%
Shs Outstand 23.56M
Perf Week -6.86%
Market Cap 3.02B
Forward P/E 10.09
EPS next Y 12.74
Insider Trans -1.06%
Shs Float 23.00M
Perf Month -6.28%
Income 125.20M
PEG 2.28
EPS next Q 1.53
Inst Own 99.93%
Short Float 5.76%
Perf Quarter 6.20%
Sales 4.43B
P/S 0.68
EPS this Y 27.88%
Inst Trans -1.39%
Short Ratio 3.96
Perf Half Y 43.32%
Book/sh 52.72
P/B 2.44
EPS next Y 26.43%
ROA 5.71%
Short Interest 1.32M
Perf Year 46.09%
Cash/sh 14.05
P/C 9.15
EPS next 5Y 11.02%
ROE 11.88%
52W Range 82.18 - 153.60
Perf YTD 6.95%
Dividend Est. 0.46 (0.36%)
P/FCF 33.51
EPS past 5Y 33.81%
ROI 7.92%
52W High -16.30%
Beta 1.50
Dividend TTM 0.48 (0.37%)
Quick Ratio 1.26
Sales past 5Y 8.95%
Gross Margin 8.55%
52W Low 56.45%
ATR (14) 6.18
Dividend Ex-Date Feb 15, 2024
Current Ratio 1.26
EPS Y/Y TTM -56.80%
Oper. Margin 4.17%
RSI (14) 37.54
Volatility 4.78% 3.76%
Employees 15000
Debt/Eq 0.35
Sales Y/Y TTM -16.84%
Profit Margin 2.83%
Recom 1.58
Target Price 162.92
Option/Short Yes / Yes
LT Debt/Eq 0.27
EPS Q/Q 35.51%
Payout 4.45%
Rel Volume 1.45
Prev Close 138.08
Sales Surprise 0.17%
EPS Surprise 11.29%
Sales Q/Q -12.43%
Earnings Apr 30 BMO
Avg Volume 334.87K
Price 128.56
SMA20 -11.00%
SMA50 -8.38%
SMA200 8.29%
Trades
Volume 139,024
Change -6.89%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-11-24 Initiated
JP Morgan
Overweight
$168
Feb-07-24 Reiterated
TD Cowen
Outperform
$141 → $178
Jan-29-24 Initiated
Deutsche Bank
Buy
$148
Sep-18-23 Initiated
UBS
Neutral
$110
Aug-21-23 Upgrade
Wolfe Research
Peer Perform → Outperform
$132
Jun-12-23 Initiated
Jefferies
Buy
$110
May-01-23 Downgrade
BofA Securities
Neutral → Underperform
$101 → $91
Jun-28-22 Initiated
Credit Suisse
Outperform
$102
Apr-08-22 Downgrade
BofA Securities
Buy → Neutral
$76
Jun-22-21 Resumed
Stifel
Buy
$70
Jun-08-21 Upgrade
Vertical Research
Hold → Buy
$85
Jun-07-21 Downgrade
Goldman
Buy → Neutral
$83 → $71
Jun-04-21 Downgrade
Wolfe Research
Outperform → Peer Perform
May-05-21 Reiterated
Cowen
Outperform
$72 → $88
Mar-26-21 Initiated
Vertical Research
Hold
$72
Feb-03-21 Reiterated
Cowen
Outperform
$46 → $55
Jan-04-21 Upgrade
Stephens
Equal-Weight → Overweight
$38 → $60
Dec-10-20 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$55
Nov-24-20 Upgrade
Citigroup
Neutral → Buy
$35 → $47
Nov-03-20 Reiterated
Cowen
Outperform
$39 → $46
Show Previous Ratings
Today 10:26AM
08:43AM
Apr-23-24 10:01AM
Apr-18-24 05:03AM
Apr-08-24 12:10PM
02:44PM
Loading…
Apr-05-24 02:44PM
Mar-28-24 06:05PM
Mar-19-24 01:03PM
Mar-18-24 06:00PM
Mar-14-24 09:27AM
Mar-08-24 11:31AM
07:47AM
Mar-07-24 04:53PM
(Investor's Business Daily) +5.97%
Feb-15-24 08:25AM
Feb-13-24 02:33PM
12:45PM
Loading…
12:45PM
12:14PM
11:44AM
08:50AM
07:00AM
Feb-07-24 04:06PM
10:01AM
12:21AM
(Thomson Reuters StreetEvents)
Feb-06-24 02:11PM
01:12PM
09:30AM
08:43AM
07:20AM
06:38AM
06:30AM
(Associated Press Finance)
06:00AM
Loading…
06:00AM
Feb-02-24 02:49PM
Jan-30-24 10:00AM
Jan-08-24 03:08PM
Dec-22-23 09:40AM
Dec-05-23 03:26PM
Dec-01-23 09:40AM
Nov-17-23 12:07PM
11:03AM
Nov-15-23 09:30AM
Nov-02-23 08:50AM
08:25AM
Nov-01-23 12:20PM
Oct-28-23 12:22PM
02:12AM
(Thomson Reuters StreetEvents)
Oct-27-23 04:21PM
09:30AM
08:28AM
07:34AM
07:15AM
06:09AM
(Associated Press Finance)
06:00AM
Oct-25-23 11:55AM
Oct-23-23 11:47AM
(Investor's Business Daily)
Oct-20-23 10:00AM
Oct-05-23 02:55AM
Oct-04-23 12:24PM
Sep-28-23 06:56AM
Sep-27-23 09:49AM
Sep-20-23 11:45AM
Sep-16-23 01:01AM
Aug-28-23 02:26PM
10:11AM
Aug-21-23 09:44AM
Aug-08-23 02:53PM
Aug-07-23 05:14PM
03:49PM
02:47PM
(The Wall Street Journal)
02:04PM
Aug-01-23 08:43AM
Jul-31-23 06:00PM
Jul-30-23 04:55AM
Jul-29-23 03:23AM
(Thomson Reuters StreetEvents)
Jul-28-23 01:00PM
09:30AM
08:46AM
07:15AM
06:07AM
Jul-26-23 09:15AM
Jul-21-23 10:00AM
Jul-19-23 11:01AM
(Investor's Business Daily) +9.28%
Jul-11-23 10:17AM
Jul-10-23 05:25PM
Jul-07-23 05:00PM
Jun-30-23 08:23PM
Jun-28-23 05:10PM
Jun-21-23 08:00PM
Jun-15-23 01:29PM
Jun-11-23 10:17AM
Jun-09-23 12:31PM
Jun-08-23 01:00PM
11:20AM
Jun-07-23 06:47PM
May-24-23 06:01PM
May-21-23 02:40PM
May-15-23 08:28AM
04:00AM
May-09-23 07:07AM
May-01-23 02:06PM
Apr-29-23 05:32AM
(Thomson Reuters StreetEvents)
ArcBest Corp. is a logistics company which provides end-to-end supply chain services with a focus on innovation. It operates through the Asset-Based and Asset-Light business segments. The Asset-Based segment includes national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment consists of logistics services using third-party vendors to provide transportation services. The company was founded in 1923 and is headquartered in Fort Smith, AR.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Gattis Erin K CHIEF HUMAN RESOURCES OFFICER Mar 01 '24 Sale 141.58 2,000 283,164 32,247 Mar 04 05:34 PM Stipp Janice E Director Nov 15 '23 Sale 122.42 3,390 415,004 17,710 Nov 17 09:59 AM Beasley John Matthew CFO and Treasurer(1) Sep 14 '23 Buy 104.98 1,000 104,980 5,392 Sep 15 04:18 PM MCELLIGOTT KATHLEEN D Director Sep 01 '23 Sale 110.24 5,000 551,200 18,900 Sep 05 04:17 PM Anderson Dennis L II Chief Strategy Officer Aug 23 '23 Sale 104.74 1,962 205,507 29,130 Aug 24 09:06 AM Anderson Dennis L II Chief Strategy Officer Aug 22 '23 Sale 107.27 5,379 577,025 31,092 Aug 24 09:06 AM Philip Craig E Director Aug 22 '23 Sale 106.60 2,700 287,820 28,400 Aug 23 04:21 PM Philip Craig E Director Aug 17 '23 Sale 102.22 3,700 378,214 31,100 Aug 18 11:18 AM SPINNER STEVEN Director Aug 11 '23 Sale 109.00 1,679 183,011 7,100 Aug 14 12:47 PM SPINNER STEVEN Director Aug 10 '23 Sale 110.07 2,321 255,472 8,779 Aug 14 12:47 PM MCREYNOLDS JUDY R Chairman, President & CEO Aug 09 '23 Sale 109.08 9,557 1,042,478 46,997 Aug 10 12:09 PM Johns Michael R Chief Legal Officer & Corp Sec Aug 09 '23 Sale 111.40 8,947 996,696 24,162 Aug 10 04:07 PM MCREYNOLDS JUDY R Chairman, President & CEO Aug 08 '23 Sale 110.09 15,443 1,700,120 56,534 Aug 10 12:09 PM Newcity Michael E SVP - Chf Innovation Offcr(1) Aug 03 '23 Sale 117.51 11,913 1,399,897 24,767 Aug 04 12:03 PM Gattis Erin K Chief Human Resources Officer Aug 02 '23 Sale 115.32 7,471 861,572 34,247 Aug 04 11:40 AM RUNSER SETH President of ABF Freight Aug 02 '23 Sale 115.07 5,466 628,973 18,534 Aug 03 04:18 PM
Index NDX, S&P 500
P/E -
EPS (ttm) -7.34
Insider Own 0.50%
Shs Outstand 159.00M
Perf Week 4.76%
Market Cap 19.55B
Forward P/E 50.30
EPS next Y 2.45
Insider Trans 0.89%
Shs Float 158.11M
Perf Month -11.29%
Income -1161.00M
PEG -
EPS next Q 0.04
Inst Own 90.68%
Short Float 3.34%
Perf Quarter -12.52%
Sales 4.50B
P/S 4.34
EPS this Y 2.09%
Inst Trans 2.72%
Short Ratio 3.19
Perf Half Y 7.98%
Book/sh 36.13
P/B 3.40
EPS next Y 178.57%
ROA -10.38%
Short Interest 5.27M
Perf Year -41.69%
Cash/sh 6.63
P/C 18.55
EPS next 5Y 22.90%
ROE -18.81%
52W Range 89.00 - 217.60
Perf YTD -11.65%
Dividend Est. -
P/FCF 69.32
EPS past 5Y -
ROI -14.66%
52W High -43.47%
Beta 1.21
Dividend TTM -
Quick Ratio 1.29
Sales past 5Y 7.40%
Gross Margin 60.97%
52W Low 38.22%
ATR (14) 4.78
Dividend Ex-Date -
Current Ratio 1.66
EPS Y/Y TTM 73.83%
Oper. Margin -1.62%
RSI (14) 44.73
Volatility 3.38% 3.63%
Employees 12010
Debt/Eq 0.39
Sales Y/Y TTM -1.72%
Profit Margin -25.78%
Recom 2.46
Target Price 151.55
Option/Short Yes / Yes
LT Debt/Eq 0.38
EPS Q/Q -24.92%
Payout -
Rel Volume 0.28
Prev Close 121.05
Sales Surprise 3.19%
EPS Surprise 652.69%
Sales Q/Q 3.60%
Earnings May 02 AMC
Avg Volume 1.66M
Price 123.02
SMA20 -2.08%
SMA50 -6.84%
SMA200 -11.47%
Trades
Volume 134,164
Change 1.63%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-16-24 Downgrade
HSBC Securities
Buy → Hold
Jan-04-24 Downgrade
TD Cowen
Outperform → Market Perform
$144
Dec-18-23 Upgrade
Scotiabank
Sector Perform → Sector Outperform
$185
Dec-15-23 Upgrade
Bernstein
Underperform → Mkt Perform
Dec-14-23 Initiated
Stephens
Overweight
$170
Dec-14-23 Initiated
Guggenheim
Buy
$155
Dec-13-23 Initiated
Wolfe Research
Outperform
$175
Dec-12-23 Downgrade
BofA Securities
Neutral → Underperform
$140 → $100
Dec-11-23 Upgrade
Citigroup
Sell → Neutral
$85 → $120
Nov-10-23 Downgrade
Canaccord Genuity
Buy → Hold
$210 → $120
Sep-28-23 Initiated
Bernstein
Underperform
$111
Jul-05-23 Resumed
JP Morgan
Neutral
$235
Jan-25-23 Downgrade
Argus
Buy → Hold
Jan-05-23 Initiated
Scotiabank
Sector Perform
$216
Dec-12-22 Downgrade
Citigroup
Neutral → Sell
$200 → $180
Dec-07-22 Initiated
RBC Capital Mkts
Outperform
$282
Oct-04-22 Upgrade
SVB Leerink
Mkt Perform → Outperform
$220 → $270
Sep-28-22 Upgrade
Evercore ISI
In-line → Outperform
$170 → $250
Aug-25-22 Initiated
Credit Suisse
Neutral
$230
Jul-13-22 Downgrade
Barclays
Equal Weight → Underweight
$350 → $150
Show Previous Ratings
Today 06:03AM
Apr-25-24 10:02AM
08:53AM
Apr-21-24 08:30AM
Apr-19-24 02:05PM
12:10PM
Loading…
12:10PM
Apr-18-24 01:30PM
08:00AM
Apr-17-24 09:30AM
Apr-15-24 05:40AM
Apr-12-24 09:00AM
06:21AM
05:49AM
Apr-10-24 08:16AM
Apr-09-24 11:37PM
05:28PM
Loading…
05:28PM
04:32PM
04:28PM
04:18PM
04:05PM
Apr-05-24 02:27PM
12:45PM
Apr-04-24 05:00PM
Apr-02-24 09:45AM
Mar-30-24 07:43PM
Mar-26-24 08:02AM
Mar-25-24 06:17AM
Mar-21-24 06:37PM
05:44AM
05:12AM
05:01AM
Loading…
05:01AM
Mar-18-24 12:40PM
Mar-17-24 08:50AM
Mar-14-24 07:42PM
Mar-13-24 06:43AM
Mar-12-24 04:50PM
02:41PM
01:57PM
Mar-08-24 08:45AM
Mar-07-24 03:00PM
08:45AM
Mar-02-24 02:30PM
Feb-28-24 05:52AM
Feb-27-24 03:40AM
03:09AM
Feb-26-24 06:29PM
11:00AM
Feb-24-24 06:50AM
Feb-23-24 07:59AM
Feb-21-24 07:42PM
09:00AM
Feb-20-24 10:25AM
Feb-14-24 07:00PM
09:40AM
Feb-09-24 11:19AM
07:52AM
(Thomson Reuters StreetEvents)
07:39AM
05:45AM
01:32AM
Feb-08-24 06:30PM
05:24PM
04:34PM
04:24PM
(Associated Press Finance)
04:05PM
09:14AM
Feb-05-24 09:16AM
Feb-01-24 09:10PM
Jan-30-24 07:31AM
Jan-29-24 07:49PM
Jan-28-24 09:25AM
Jan-23-24 08:45PM
Jan-19-24 08:25AM
Jan-18-24 07:52AM
05:04AM
Jan-17-24 12:04PM
Jan-16-24 10:11AM
Jan-15-24 07:00AM
Jan-12-24 09:45AM
Jan-11-24 09:45AM
Jan-09-24 05:28PM
02:02PM
09:00AM
07:05AM
05:38AM
03:34AM
Jan-08-24 12:45PM
Jan-05-24 09:15AM
Jan-04-24 08:17PM
04:05PM
09:15AM
Dec-28-23 01:02PM
Dec-27-23 10:45AM
Dec-22-23 03:00PM
Dec-21-23 09:35AM
Dec-19-23 05:28PM
(The Wall Street Journal) +8.08%
04:42PM
04:05PM
01:26PM
11:11AM
11:02AM
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Thaysen Jacob Chief Executive Officer Feb 22 '24 Buy 135.29 7,330 991,672 14,861 Feb 26 08:57 AM Hoyt Aimee L SVP, Chief People Officer Nov 07 '23 Sale 112.84 315 35,545 8,314 Nov 09 04:22 PM TOUSI SUSAN H SVP, Chief Commercial Officer Aug 22 '23 Sale 167.04 500 83,520 45,524 Aug 24 04:19 PM TOUSI SUSAN H SVP, Chief Commercial Officer Jul 24 '23 Sale 190.08 500 95,040 46,022 Jul 26 06:14 PM TOUSI SUSAN H SVP, Chief Commercial Officer Jun 22 '23 Sale 200.00 500 100,000 46,522 Jun 26 05:23 PM EPSTEIN ROBERT S Director May 25 '23 Option Exercise 71.09 7,600 540,284 14,764 May 25 04:34 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite